Omeros (OMER) stock plummeted 5.77% during intraday trading on Thursday, marking a significant decline for the healthcare company.

The sharp drop appears to be driven by mixed analyst opinions on the stock, with healthcare sector companies receiving substantial coverage from analysts who have expressed divided views on Omeros's prospects.

Analyst coverage and ratings often influence investor sentiment, and the publication of mixed opinions before the market open likely contributed to the selling pressure that drove Omeros shares lower during the trading session.